Product Images Pregabalin

This is a packaging label for a medication called "Lyrica 50mg (CV)" manufactured by Laurus Labs Limited. It comes in a capsule form and is packed by Bryant Ranck Prepack. The label also includes the dosage, the expiration date, the NDC number, and the storage information. There is a warning to keep the medication out of reach of children.*

The text seems to be showing data related to the percentage of patients improved and the percentage improvement in pain from baseline. However, the formatting is not clear and some characters are not readable, making it difficult to provide an accurate description.*

The text is describing a table showing the percent improvement in pain from baseline among patients, after taking Pregabalin 160 mg for three days. The table contains percentages ranging from 2% to 100%. There are also some numerical values, but their meaning is unclear. The text is not available and does not provide additional information about the context of the table.*

This appears to be a chart showing different medications and the percentage of patients who experienced improvement in pain. The medications listed include pregabalin at various doses and frequencies. However, the chart is not entirely clear and there are some missing values.*

This is a clinical trial report comparing the effectiveness of Fregabalin (100mg, three times a day) and Pregabalin (80mg, three times a day) with a Placebo drug. The improvement of patients was measured using a scale, and the percentage of patients who improved through the treatment was reported. There is also a chart showing percentages of improvements in pain levels from the baseline among treated patents.*

This appears to be a chart displaying different doses of medication (Pregabalin) and a placebo in terms of their effects on pain. It shows the percent of patients and percent improvement in pain from baseline for each dose. However, the text is difficult to read and there are errors in the spelling of the medication name.*

This is a partial data table with information on estimated percentage of subjects without LTR (likely to return) for a study comparing Pregabain and Plcebo. There are different percentages presented for each treatment, but no explanation or context is given for these results. The table also includes an indication of days, but it's not clear how these correspond to the percentages presented.*